Think

Search This Blog

New A.L.S. Treatment Lacks Evidence of Benefit, F.D.A. Panel Finds

March 30, 2022

Get link
Facebook
X
Pinterest
Email
Other Apps

BY PAM BELLUCK | NYTimes Health | Disclosure

Get link
Facebook
X
Pinterest
Email
Other Apps

Comments

Drug Company to Share Revenues With Indigenous People Who Donated Their Genes

Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop drugs for obesity and diabetes. Brendan Borrell | NYTimes Health | Disclosure

Kennedy’s Plan for the Drug Crisis: A Network of ‘Healing Farms’

The positions of Robert F. Kennedy Jr. on vaccines and drug companies are well known. His approach to addiction has been far less scrutinized. Jan Hoffman | NYTimes Health | Disclosure

For Children in Rural Mozambique, the Future Comes Into Focus

One doctor is showing nurses, teachers and parents how to spot eye problems, many of which can be easily treated. Surgery, and even just glasses, can be life-changing, and keep kids in school. Kang-Chun Cheng and Stephanie Nolen | NYTimes Health | Disclosure

Yes, Some Vaccines Contain Aluminum. That’s a Good Thing.

R.F.K. Jr. and others have blamed the ingredient for allergies and other illnesses. Scientists say it actually bolsters the immune response. Teddy Rosenbluth | NYTimes Health | Disclosure

Telemedicine for Seniors Gets a Last-Minute Reprieve

Some older Americans have come to depend on virtual consultations with doctors, covered by Medicare. To keep that option in the future, Congress will have to act quickly. Paula Span | NYTimes Health | Disclosure

New A.L.S. Treatment Lacks Evidence of Benefit, F.D.A. Panel Finds

Comments

Post a Comment